Sarasota, FL -- (SBWire) -- 10/31/2017 --The global cardiovascular monitoring and diagnostic devices market was valued at around USD 1.70 billion in 2015 and is expected to reach approximately USD 2.60 billion by 2021, growing at a CAGR of around 7.0% between 2016 and 2021.

Cardiovascular disease is a collective term for blood vessels and heart diseases including stroke, cardiomyopathy coronary heart disease, peripheral vascular disease, heart failure and congenital heart disease. Cardiovascular monitoring is continuous monitoring of heart activity by assessment of the patient's condition by cardiac rhythm. Cardio vascular devices measure cardiovascular pressure & cardiac output and help in diagnosis & treatment of cardio vascular diseases. Continuous cardiovascular and pulmonary monitoring can help in accurate initiation of treatment & identification. Cardio vascular monitoring devices used to monitor blood temperature, electrocardiogram, noninvasive blood pressure, arterial blood oxygen saturation, intravascular pressures, and cardiac output. These cardio vascular monitoring devices are mainly used in critical areas and emergency rooms. Cardio vascular diagnosis tests include the echocardiogram, cardiac computerized tomography (CT) scan, blood tests, electrocardiogram, cardiac catheterization, and cardiac magnetic resonance imaging (MRI).

Request Free Sample Research Report @ http://atozresearch.com/cardiovascular-monitoring-and-diagnostic-devices-market-global-industry-perspective-by-2021/

The cardiovascular monitoring and diagnostic devices market are expected to grow at the fastest rate with increasing medical tourism and rising education towards heart functioning. Medical tourism is growing sector and deals with the purpose of receiving medical treatment across international borders. The cardiovascular monitoring and diagnostic devices market have a strong hold on market and it is accelerated by rising cardiovascular diseases and unhealthy lifestyle. Moreover, the market for cardiovascular monitoring and diagnostic devices is propelled by rising consumption of smoking & alcohol. On another hand, the high cost of treatment and uncertainty in reimbursement may hamper the market growth of cardiovascular monitoring and diagnostic devices market. Nonetheless, untapped market and increasing investment by the manufacturer in the field of medical device manufacturing may generate new opportunities in coming years.

On the basis of product type, cardiovascular monitoring, and diagnostic devices market is segmented into ECG systems, Holter monitors, event monitors, implantable loop recorders, ECG management systems. Among all these segments, ECG systems dominated the monitoring and diagnostic devices market. ECG systems segment is further bifurcated into resting ECG systems and stress ECG systems. Resting ECG systems was leading sub-segment of ECG systems market and it is expected to remain dominant in coming years. Holter monitors segment is growing at the significant growth rate and it is expected to grow at CAGR of around 5.4% in the forecast period.

On the basis of region, cardiovascular monitoring and diagnostic devices market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In 2015, North America cardiovascular monitoring and diagnostic devices market was dominated and it is due to increase expenditure on research and development of cardiovascular diseases. Europe region was the second largest market for cardiovascular monitoring and diagnostic devices and it is projected to grow at significant growth rate as a result of increasing prevalence of cardiovascular diseases. Asia Pacific cardiovascular monitoring and diagnostic devices market is growing at a noticeable growth rate and this market is dominated by India and China. Increasing government initiatives has made the huge contribution for Indian cardiovascular monitoring and diagnostic devices market and thus this region will maintain its dominance in coming years followed by China.

Key participants operating in the cardiovascular monitoring and diagnostic devices market includes Boston Scientific Corporation, Welch Allyn, Inc., FUKUDA DENSHI Co., Ltd., GE Healthcare, Sorin Group, Johnson & Johnson, Medtronic, Inc, Nihon Kohden Corporation, Philips Healthcare, Siemens Healthcare, Spacelabs Healthcare, St. Jude Medical, Inc and Welch Allyn, Inc.

About A to Z Research
A to Z Research is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations. A to Z Research is the comprehensive collection of market intelligence products and services available on air. We have market research reports from number of leading publishers and update our collection daily to provide our clients with the instant online access to our database. With access to this database, our clients will be able to benefit from expert insights on global industries, products, and market trends.